Skip to main content

and
  1. Article

    Open Access

    Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy

    Combination of oncolytic vaccinia virus therapy with conventional chemotherapy has shown promise for tumor therapy. However, side effects of chemotherapy including thrombocytopenia, still remain problematic.

    Julia B Sturm, Michael Hess, Stephanie Weibel in Journal of Translational Medicine (2012)

  2. No Access

    Protocol

    Real-Time Imaging of Tumors Using Replication-Competent Light-Emitting Microorganisms

    Early detection of cancer and metastases is pivotal to the success of subsequent treatment intervention. In recent years, the use of live microorganisms, such as viruses and bacteria, has gained substantial re...

    Yong A. Yu, Stephanie Weibel in In Vivo Cellular Imaging Using Fluorescent… (2012)

  3. Article

    Open Access

    Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice

    We have shown that insertion of the three vaccinia virus (VACV) promoter-driven foreign gene expression cassettes encoding Renilla luciferase-Aequorea GFP fusion protein, β-galactosidase, and β-glucuronidase into...

    Nanhai G Chen, Yong A Yu, Qian Zhang, Aladar A Szalay in Journal of Translational Medicine (2011)

  4. Article

    Open Access

    Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus

    Oncolytic viruses show promise for treating cancer. However, to assess therapeutic efficacy and potential toxicity, a noninvasive imaging modality is needed. This study aimed to determine if insertion of the h...

    Dana Haddad, Nanhai G Chen, Qian Zhang, Chun-Hao Chen in Journal of Translational Medicine (2011)

  5. Article

    Open Access

    Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection

    In principle, the elimination of malignancies by oncolytic virotherapy could proceed by different mechanisms - e.g. tumor cell specific oncolysis, destruction of the tumor vasculature or an anti-tumoral immuno...

    Stephanie Weibel, Viktoria Raab, Yong A Yu, Andrea Worschech, Ena Wang in BMC Cancer (2011)

  6. Article

    Open Access

    The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation

    As a new anticancer treatment option, vaccinia virus (VACV) has shown remarkable antitumor activities (oncolysis) in preclinical studies, but potential infection of other organs remains a safety concern. We pr...

    Qian Zhang, Chunguang Liang, Yong A. Yu, Nanhai Chen in Molecular Genetics and Genomics (2009)

  7. Article

    Open Access

    Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

    GLV-1h68 is an attenuated recombinant vaccinia virus (VACV) that selectively colonizes established human xenografts inducing their complete regression.

    Andrea Worschech, Nanhai Chen, Yong A Yu, Qian Zhang, Zoltan Pos in BMC Genomics (2009)

  8. Article

    Open Access

    Oncolytic vaccinia therapy of squamous cell carcinoma

    Novel therapies are necessary to improve outcomes for patients with squamous cell carcinomas (SCC) of the head and neck. Historically, vaccinia virus was administered widely to humans as a vaccine and led to t...

    Zhenkun Yu, Sen Li, Peter Brader, Nanhai Chen, Yong A Yu, Qian Zhang in Molecular Cancer (2009)

  9. Article

    Open Access

    A Novel Recombinant Vaccinia Virus Expressing the Human Norepinephrine Transporter Retains Oncolytic Potential and Facilitates Deep-Tissue Imaging

    Noninvasive and repetitive monitoring of a virus in target tissues and/or specific organs of the body is highly desirable for the development of safe and efficient cancer virotherapeutics. We have previously s...

    Nanhai Chen, Qian Zhang, Yong A. Yu, Jochen Stritzker, Peter Brader in Molecular Medicine (2009)

  10. Article

    Correction: Corrigendum: Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

    Nat. Biotechnol. 22, 313–320 (2003) On page 319, column 1, line 9 from bottom, the phrase “subcutaneous colon fibrosarcoma” should have read “subcutaneous fibrosarcoma.”

    Yong A Yu, Shahrokh Shabahang, Tatyana M Timiryasova, Qian Zhang in Nature Biotechnology (2004)

  11. No Access

    Article

    Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

    We have shown that bacteria injected intravenously into live animals entered and replicated in solid tumors and metastases. The tumor-specific amplification process was visualized in real time using luciferase...

    Yong A Yu, Shahrokh Shabahang, Tatyana M Timiryasova, Qian Zhang in Nature Biotechnology (2004)

  12. No Access

    Article

    Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals

    Early detection of tumors and their metastases is crucial for the prognosis of cancer treatment. Traditionally, tumor detection is achieved by various methods, including magnetic resonance imaging and computer...

    Yong A. Yu, Tatyana Timiryasova, Qian Zhang in Analytical and Bioanalytical Chemistry (2003)